Cytarabine is a chemotherapy drug used to treat cancers of white blood cells. It works as an antimetabolite by being converted into its active triphosphate form, which then gets incorporated into DNA during the S-phase of cell division. This incorporation interferes with DNA synthesis and causes DNA fragmentation, leading to apoptosis. However, cancer cells can develop resistance by overexpressing drug transporters and deaminase enzymes that inactivate cytarabine or reduce its conversion to the active triphosphate form.
This document analyzes collagenolytic activity and reactivity of MMP-1 and MMP-13 in UV-treated skin. It finds that MMP-1 expression and activity are strongly upregulated in skin exposed to UV light, while MMP-13 is barely detected. Organ culture fluid from UV-treated skin degrades type I collagen, primarily generating 3/4 and 1/4 fragments. This collagen-degrading activity is inhibited by over 95% when treated with an antibody targeting MMP-1, indicating that MMP-1 is the predominant collagenase responsible for collagen damage caused by UV exposure in human skin.
A reading report for <Obesity-induced DNA hypermethylation of the adiponectin...星云 王
1. Obesity causes inflammation which increases DNMT1 expression and activity, leading to DNA hypermethylation of the adiponectin gene promoter and reduced adiponectin expression.
2. Inhibition of DNMT with RG108 prevents obesity-induced hypermethylation of the adiponectin gene, increasing adiponectin levels and improving insulin resistance.
3. RG108 treatment in obese mice reduces adiponectin gene hypermethylation, elevates adiponectin levels, and improves glucose tolerance and insulin signaling without affecting body weight or organ function.
This document discusses a study aiming to elucidate the mechanism by which the HDAC inhibitor Apicidin induces expression of the drug efflux pump P-glycoprotein (P-gp), which may lead to multidrug resistance. The study found that Apicidin treatment activated the PI3K pathway, leading to phosphorylation of the transcription factor SP1. Phosphorylated SP1 then signals chromatin remodeling and activation of the P-gp promoter. This occurred independently of changes in DNA methylation and required the Y-box and GC box regions of the promoter. Blocking the PI3K pathway prevented Apicidin-induced P-gp expression.
This study evaluated using hyaluronic acid-polyethyleneimine (HA-PEI) conjugates to deliver small interfering RNA (siRNA) targeting TNF-α gene in macrophages for potential treatment of type 1 diabetes. HA-PEI conjugates were synthesized and characterized. The conjugates formed nanoparticles around 90nm in size that efficiently encapsulated TNF-α siRNA. These nanoparticles were efficiently taken up by macrophages and significantly reduced TNF-α levels, as shown by RT-PCR, more so than Lipofectin-complexed siRNA controls. The results suggest this nanoparticle system may help limit inflammation by delivering TNF-α silencing siRNA to macrophages.
Antituberculosis drugs are used to treat tuberculosis, an infectious lung disease. The first line drugs include isoniazid, rifampicin, pyrazinamide, ethambutol and streptomycin which are generally bactericidal. Second line drugs are used when there is resistance and include fluoroquinolones, aminoglycosides, cycloserine and para-aminosalicylic acid. India's Revised National Tuberculosis Control Programme employs DOTS therapy with the aim of improving treatment adherence and outcomes for patients.
Metabolic investigation of segmental overgrowth: new insights in pathogenic m...BiologInc
This document summarizes a study investigating the metabolic mechanisms underlying segmental overgrowth disorders and potential treatments. The study found that mutations in the PI3K-AKT pathway, such as in PIK3CA and AKT1, lead to increased cell proliferation and metabolism. Functional studies showed that cell lines with PIK3CA mutations had increased AKT phosphorylation and responded strongly to growth factors, while AKT1 mutant cell lines responded less. Treatment with PI3K or mTOR inhibitors normalized the metabolic profile in both AKT1 and PIK3CA mutant cell lines, suggesting these may be effective treatments. The study provides new insights into the molecular mechanisms and potential targeted therapies for segmental overgrowth disorders.
Sorin Tunaru conducted research to identify and characterize the nicotinic acid receptor. He identified that the mouse Puma-G receptor and the human HM74a receptor are G-protein coupled receptors activated by nicotinic acid. Both receptors are expressed mainly in adipose tissue and immune cells. Experiments in mice lacking the Puma-G gene showed that it mediates the antilipolytic effect of nicotinic acid in vivo by inhibiting lipolysis in adipose tissue. Tunaru also characterized the binding pocket of the HM74a receptor for nicotinic acid and identified residues critical for binding. Through screening, he found a family of compounds that are selective agonists of the HM74 receptor but not the HM74
Cytarabine is a chemotherapy drug used to treat cancers of white blood cells. It works as an antimetabolite by being converted into its active triphosphate form, which then gets incorporated into DNA during the S-phase of cell division. This incorporation interferes with DNA synthesis and causes DNA fragmentation, leading to apoptosis. However, cancer cells can develop resistance by overexpressing drug transporters and deaminase enzymes that inactivate cytarabine or reduce its conversion to the active triphosphate form.
This document analyzes collagenolytic activity and reactivity of MMP-1 and MMP-13 in UV-treated skin. It finds that MMP-1 expression and activity are strongly upregulated in skin exposed to UV light, while MMP-13 is barely detected. Organ culture fluid from UV-treated skin degrades type I collagen, primarily generating 3/4 and 1/4 fragments. This collagen-degrading activity is inhibited by over 95% when treated with an antibody targeting MMP-1, indicating that MMP-1 is the predominant collagenase responsible for collagen damage caused by UV exposure in human skin.
A reading report for <Obesity-induced DNA hypermethylation of the adiponectin...星云 王
1. Obesity causes inflammation which increases DNMT1 expression and activity, leading to DNA hypermethylation of the adiponectin gene promoter and reduced adiponectin expression.
2. Inhibition of DNMT with RG108 prevents obesity-induced hypermethylation of the adiponectin gene, increasing adiponectin levels and improving insulin resistance.
3. RG108 treatment in obese mice reduces adiponectin gene hypermethylation, elevates adiponectin levels, and improves glucose tolerance and insulin signaling without affecting body weight or organ function.
This document discusses a study aiming to elucidate the mechanism by which the HDAC inhibitor Apicidin induces expression of the drug efflux pump P-glycoprotein (P-gp), which may lead to multidrug resistance. The study found that Apicidin treatment activated the PI3K pathway, leading to phosphorylation of the transcription factor SP1. Phosphorylated SP1 then signals chromatin remodeling and activation of the P-gp promoter. This occurred independently of changes in DNA methylation and required the Y-box and GC box regions of the promoter. Blocking the PI3K pathway prevented Apicidin-induced P-gp expression.
This study evaluated using hyaluronic acid-polyethyleneimine (HA-PEI) conjugates to deliver small interfering RNA (siRNA) targeting TNF-α gene in macrophages for potential treatment of type 1 diabetes. HA-PEI conjugates were synthesized and characterized. The conjugates formed nanoparticles around 90nm in size that efficiently encapsulated TNF-α siRNA. These nanoparticles were efficiently taken up by macrophages and significantly reduced TNF-α levels, as shown by RT-PCR, more so than Lipofectin-complexed siRNA controls. The results suggest this nanoparticle system may help limit inflammation by delivering TNF-α silencing siRNA to macrophages.
Antituberculosis drugs are used to treat tuberculosis, an infectious lung disease. The first line drugs include isoniazid, rifampicin, pyrazinamide, ethambutol and streptomycin which are generally bactericidal. Second line drugs are used when there is resistance and include fluoroquinolones, aminoglycosides, cycloserine and para-aminosalicylic acid. India's Revised National Tuberculosis Control Programme employs DOTS therapy with the aim of improving treatment adherence and outcomes for patients.
Metabolic investigation of segmental overgrowth: new insights in pathogenic m...BiologInc
This document summarizes a study investigating the metabolic mechanisms underlying segmental overgrowth disorders and potential treatments. The study found that mutations in the PI3K-AKT pathway, such as in PIK3CA and AKT1, lead to increased cell proliferation and metabolism. Functional studies showed that cell lines with PIK3CA mutations had increased AKT phosphorylation and responded strongly to growth factors, while AKT1 mutant cell lines responded less. Treatment with PI3K or mTOR inhibitors normalized the metabolic profile in both AKT1 and PIK3CA mutant cell lines, suggesting these may be effective treatments. The study provides new insights into the molecular mechanisms and potential targeted therapies for segmental overgrowth disorders.
Sorin Tunaru conducted research to identify and characterize the nicotinic acid receptor. He identified that the mouse Puma-G receptor and the human HM74a receptor are G-protein coupled receptors activated by nicotinic acid. Both receptors are expressed mainly in adipose tissue and immune cells. Experiments in mice lacking the Puma-G gene showed that it mediates the antilipolytic effect of nicotinic acid in vivo by inhibiting lipolysis in adipose tissue. Tunaru also characterized the binding pocket of the HM74a receptor for nicotinic acid and identified residues critical for binding. Through screening, he found a family of compounds that are selective agonists of the HM74 receptor but not the HM74
This document summarizes a lecture on inhibitors of cell wall synthesis and protein biosynthesis. It discusses various classes of antibiotics, including carbapenems, monobactams, beta-lactamase inhibitors, peptide antibiotics (polymyxins, glycopeptides, bacitracin), and protein synthesis inhibitors. It provides details on specific antibiotics, their mechanisms of action, spectra of activity, pharmacokinetics, toxicities, and clinical uses. The lecture was presented by Dr. G. Kattam Maiyoh.
This document discusses new advances in the management of IgA nephropathy. It outlines current treatment options including corticosteroids and their limitations. Recent clinical trials on corticosteroid use are summarized. Novel therapies targeting the pathogenesis of IgA nephropathy through intestinal immunity, B cells, complement pathways, and the proteasome are discussed. Several drugs are in clinical trials. Experimental therapies involving IgA1 proteases and microbiome modulation are also proposed.
Magnetic nanoparticles are used in affinity chromatography to efficiently separate proteins. Proteins play important roles in the body but require isolation for various purposes. Magnetic nanoparticles allow for fast, scalable, and automated separation of a target protein from others in a single step. Specifically, the document discusses how magnetic nanoparticles were used to isolate tissue plasminogen activator, an enzyme involved in breaking down blood clots. The nanoparticles were bound to the target protein and then several washes removed nonspecifically bound proteins. An elution step released the pure target protein. Analysis found the target protein was present in initial and waste samples but purified in the eluate, demonstrating the method's effectiveness.
This presentation gives information about the antimetabolites and suicide inhibitors that we are frequently using. Their mechanism and various examples are also given
Tofacitinib has been shown to significantly reduce signs and symptoms of RA as monotherapy and in combination with DMARDs. While treatments have improved, unmet needs remain like pain, fatigue, and psychological issues. ORAL Strategy showed tofacitinib + MTX was non-inferior to adalimumab + MTX. Tofacitinib provides an oral option for patients after inadequate response to csDMARDs and has an extensive safety profile from clinical trials and real-world use.
Antisense oligonucleotide therapy is a pharmacological approach that uses synthetic genetic material to inhibit protein translation by binding to mRNA. It works by blocking ribosomes, activating RNase enzymes, or forming triplex structures. Advantages include rapid manufacturing and potential for enhanced targeting. Limitations include short half-lives and difficulty directing to specific cells. Over 50 antisense compounds are in clinical trials for various diseases. The future of antisense-based therapies looks promising as more companies develop applications.
This document summarizes various targeted anticancer therapies. It discusses targeted therapies that interfere with molecular structures implicated in tumor growth like nuclear factors, cell survival factors, and angiogenesis factors. Primary targeted therapy tools are monoclonal antibodies and small synthetic molecules. Protein kinases and their role in signaling pathways are described. Examples of targeted therapies discussed include BCR-ABL tyrosine kinase inhibitors, EGFR inhibitors, HER2/NEU inhibitors, angiogenesis inhibitors targeting VEGF, mTOR inhibitors, proteasome inhibitors, MAPK pathway inhibitors, and monoclonal antibodies. Resistance mechanisms and newer agents to overcome resistance are also summarized.
Immunosuppressants are drugs that inhibit immune responses and are used for organ transplantation and autoimmune diseases. The main classes of immunosuppressants discussed are calcineurin inhibitors like cyclosporine and tacrolimus which inhibit T-cell activation, mTOR inhibitors like sirolimus and everolimus, antiproliferative drugs like azathioprine and mycophenolate mofetil which inhibit lymphocyte proliferation, glucocorticoids which inhibit cytokine production, and biological agents that target specific components of the immune system such as TNF inhibitors. Each drug has a specific mechanism of action to suppress immune responses through different pathways.
This document discusses targeted cancer therapies and their mechanisms of action. It outlines 10 hallmarks of cancer and describes targeted drugs that inhibit specific proteins and pathways involved in cancer growth. These targeted drugs include small molecule tyrosine kinase inhibitors, monoclonal antibodies, angiogenesis inhibitors, and proteosome inhibitors. Examples are provided of targeted therapies used to treat cancers like chronic myeloid leukemia, lung cancer, breast cancer, and multiple myeloma. Potential side effects of targeted therapies are also mentioned.
Bortezomib for Injection Taj Pharma SmPCTajPharmaQC
Bortezomib for Injection 1mg/2mg/3.5mg Taj Pharma: Uses, Side Effects, Interactions, Pictures, Warnings, Bortezomib Dosage & Rx Info | Bortezomib Uses, Side Effects Bortezomib : Indications, Side Effects, Warnings, Bortezomib -Drug Information –Taj Pharma, Bortezomib dose Taj pharmaceuticals Bortezomib interactions, Taj Pharmaceutical Bortezomib contraindications, Bortezomib price, Bortezomib Taj Pharma Bortezomib SmPC-Taj Pharma Stay connected to all updated on Bortezomib Taj Pharmaceuticals Mumbai. Patient Information Leaflets, SMPC.
The document describes a multiple-dose methotrexate (MTX) treatment protocol for ectopic pregnancy. On treatment days 1, 3, 5, and 7, patients receive MTX injections if their human chorionic gonadotropin (hCG) levels have declined by less than 15% from the previous measurement. Leucovorin is administered on days 2, 4, 6, and 8. hCG is measured before starting treatment and on each treatment day to assess the decline. If hCG declines by more than 15%, treatment is stopped and surveillance begins. Surveillance involves weekly hCG testing until levels fall below 5 mIU/mL.
Single dose Methotrexate- Monitoring : Medical treatment ectopicAsha Reddy
The document describes two protocols for treating ectopic pregnancies with methotrexate (MTX): a multiple-dose protocol and a single-dose protocol.
The multiple-dose protocol administers MTX and leucovorin over 8 days, monitoring hCG levels after each dose. If hCG levels decline by at least 15%, treatment continues until levels fall below 5 mIU/mL. If decline is insufficient, treatment is stopped and surveillance begins.
The single-dose protocol administers a single dose of MTX on day 1 and day 7, if needed. hCG is monitored on days 1, 4, and 7 to assess the 15% decline threshold. Complete resolution usually takes 2-3
This document provides information on the fixed-dose combination drug Instgra Tafero EM, which contains dolutegravir, tenofovir alafenamide, and emtricitabine. It is used to treat HIV-1 infection in adults and pediatric patients weighing at least 30kg. The drug works by inhibiting HIV enzymes through different mechanisms of action. Common side effects include hypersensitivity reactions, liver toxicity, and immune reconstitution syndrome. Special precautions are required regarding drug interactions and use in pregnancy.
tofacitinib (Tofacent) is an oral drug used for treating rheumatoid arthritis. It belongs to a class of drugs called Janus kinase (JAK) inhibitors. buy tofacitinib only at $6. Visit our website to know more https://emergencydrug.com/drug/tofacitinib-5mg/
Methicillin resistance in Staphylococcus aureus occurs via three main mechanisms:
1) S. aureus acquires a genetic predisposition for methicillin resistance through the staphylococcal cassette chromosome mec (SCCmec) which carries the mecA gene encoding the modified penicillin-binding protein PBP2a.
2) PBP2a has reduced affinity for beta-lactam antibiotics like methicillin allowing cell wall synthesis to continue despite their presence.
3) At therapeutic methicillin levels that inhibit other PBPs, PBP2a remains active ensuring peptidoglycan cross-linking and membrane biosynthesis, enabling methicillin-resistant S. aureus (MRSA) to survive
MM151_World Lung Cancer Conference July 2011Sharlene Adams
1) MM-151 is a mixture of three human monoclonal antibodies against EGFR that were selected to simultaneously bind non-overlapping epitopes on EGFR. Computational modeling predicted that a combination of multiple EGFR antibodies would more potently inhibit signaling than single antibodies.
2) In vitro and in vivo studies showed MM-151 was more potent than existing EGFR antibodies at inhibiting signaling from various EGFR ligands. MM-151 blocked signaling from both high and low affinity ligands, whereas existing antibodies only blocked low affinity ligands.
3) Toxicology studies in animals found MM-151 to have a similar safety profile to existing EGFR antibodies, with mainly gastrointestinal and dermatological side effects. MM-151 was
Prolactin is a protein hormone secreted by the pituitary gland that enables mammals to produce milk. It binds to receptors in the gonads, lymphoid cells, and liver. Prolactin signaling triggers pathways such as JAK-STAT and MAPK that regulate cell growth and differentiation. High levels of prolactin can disrupt the hypothalamic-pituitary-gonadal axis and cause infertility by decreasing kisspeptin and GnRH expression in the brain.
Primary Human Cell Systems Analysis of Drug MechanismsBioMAP® Systems
The document summarizes a presentation about using BioMAP human cell systems to analyze the mechanisms of drug compounds, including PPAR agonists. It describes how BioMAP uses primary human cells in disease-like conditions to generate quantitative readouts that can discriminate between clinical compounds. Profiling of PPAR agonists using BioMAP revealed both shared and unique anti-inflammatory, tissue remodeling, and prostaglandin pathway effects. Differential activities suggested priorities for therapeutic areas and potential side effects.
Quantitative Analysis of IGF1R/AKT/mTOR Pathway using Multiplex-Immunoprecipi...Thermo Fisher Scientific
Determine the efficacy of multiplex IP to targeted MS (mIP-tMS) technique for measurement of the total and phosphorylated AKT-mTOR pathway targets and to evaluate whether mIP-tMS assays are as effective as the current singleplex immunoassay (Western Blot (WB) and ELISA) and multiplex Luminex assays.
The document summarizes research finding that the kinase GCN2 sustains mTORC1 suppression during amino acid deprivation by inducing the stress response protein Sestrin2. GCN2 activates the transcription factor ATF4 during amino acid starvation. ATF4 then transcriptionally upregulates Sestrin2, which is required for mTORC1 suppression. Chromatin immunoprecipitation confirms that ATF4 directly binds to the Sesn2 promoter. Sestrin2 depletion prevents mTORC1 suppression and reduces cell survival during glutamine withdrawal. Therefore, the GCN2-ATF4 pathway induces Sestrin2 to repress mTORC1 activity and promote cell survival during amino acid deprivation.
PI3KAktmTOR Intracellular Pathway and Breast Cancer Factors, Mechanism and Re...Dr Varruchi Sharma
The most recurrent cause of cancer-related deaths worldwide in women is the breast cancer. The key to diagnosis is early prediction and a curable stage but still treatment remains a great clinical challenge. Origin of the Problem: A number of studies have been carried out for the treatment of breast cancer which includes the targeted therapies and increased survival rates in women. Essential PI3K/mTOR signaling pathway activation has been observed in most breast cancers. The cell growth and tumor development in such cases involves phosphoinositide 3 kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) complex intracellular pathway. Hypothesis: Through preclinical and clinical trials, it has been observed that there are a number of other inhibitors of PI3K/Akt/mTOR pathway, which either alone or in combination with cytotoxic agents can be used for endocrine therapies. Conclusions: Structure and regulation/deregulation of mTOR provides a greater insight into the action mechanism. Also through this review, one could easily scan first and second generation inhibitors for PI3K/Akt/mTOR pathway besides targeted therapies for breast cancer and the precise role of mTOR.
This document summarizes a lecture on inhibitors of cell wall synthesis and protein biosynthesis. It discusses various classes of antibiotics, including carbapenems, monobactams, beta-lactamase inhibitors, peptide antibiotics (polymyxins, glycopeptides, bacitracin), and protein synthesis inhibitors. It provides details on specific antibiotics, their mechanisms of action, spectra of activity, pharmacokinetics, toxicities, and clinical uses. The lecture was presented by Dr. G. Kattam Maiyoh.
This document discusses new advances in the management of IgA nephropathy. It outlines current treatment options including corticosteroids and their limitations. Recent clinical trials on corticosteroid use are summarized. Novel therapies targeting the pathogenesis of IgA nephropathy through intestinal immunity, B cells, complement pathways, and the proteasome are discussed. Several drugs are in clinical trials. Experimental therapies involving IgA1 proteases and microbiome modulation are also proposed.
Magnetic nanoparticles are used in affinity chromatography to efficiently separate proteins. Proteins play important roles in the body but require isolation for various purposes. Magnetic nanoparticles allow for fast, scalable, and automated separation of a target protein from others in a single step. Specifically, the document discusses how magnetic nanoparticles were used to isolate tissue plasminogen activator, an enzyme involved in breaking down blood clots. The nanoparticles were bound to the target protein and then several washes removed nonspecifically bound proteins. An elution step released the pure target protein. Analysis found the target protein was present in initial and waste samples but purified in the eluate, demonstrating the method's effectiveness.
This presentation gives information about the antimetabolites and suicide inhibitors that we are frequently using. Their mechanism and various examples are also given
Tofacitinib has been shown to significantly reduce signs and symptoms of RA as monotherapy and in combination with DMARDs. While treatments have improved, unmet needs remain like pain, fatigue, and psychological issues. ORAL Strategy showed tofacitinib + MTX was non-inferior to adalimumab + MTX. Tofacitinib provides an oral option for patients after inadequate response to csDMARDs and has an extensive safety profile from clinical trials and real-world use.
Antisense oligonucleotide therapy is a pharmacological approach that uses synthetic genetic material to inhibit protein translation by binding to mRNA. It works by blocking ribosomes, activating RNase enzymes, or forming triplex structures. Advantages include rapid manufacturing and potential for enhanced targeting. Limitations include short half-lives and difficulty directing to specific cells. Over 50 antisense compounds are in clinical trials for various diseases. The future of antisense-based therapies looks promising as more companies develop applications.
This document summarizes various targeted anticancer therapies. It discusses targeted therapies that interfere with molecular structures implicated in tumor growth like nuclear factors, cell survival factors, and angiogenesis factors. Primary targeted therapy tools are monoclonal antibodies and small synthetic molecules. Protein kinases and their role in signaling pathways are described. Examples of targeted therapies discussed include BCR-ABL tyrosine kinase inhibitors, EGFR inhibitors, HER2/NEU inhibitors, angiogenesis inhibitors targeting VEGF, mTOR inhibitors, proteasome inhibitors, MAPK pathway inhibitors, and monoclonal antibodies. Resistance mechanisms and newer agents to overcome resistance are also summarized.
Immunosuppressants are drugs that inhibit immune responses and are used for organ transplantation and autoimmune diseases. The main classes of immunosuppressants discussed are calcineurin inhibitors like cyclosporine and tacrolimus which inhibit T-cell activation, mTOR inhibitors like sirolimus and everolimus, antiproliferative drugs like azathioprine and mycophenolate mofetil which inhibit lymphocyte proliferation, glucocorticoids which inhibit cytokine production, and biological agents that target specific components of the immune system such as TNF inhibitors. Each drug has a specific mechanism of action to suppress immune responses through different pathways.
This document discusses targeted cancer therapies and their mechanisms of action. It outlines 10 hallmarks of cancer and describes targeted drugs that inhibit specific proteins and pathways involved in cancer growth. These targeted drugs include small molecule tyrosine kinase inhibitors, monoclonal antibodies, angiogenesis inhibitors, and proteosome inhibitors. Examples are provided of targeted therapies used to treat cancers like chronic myeloid leukemia, lung cancer, breast cancer, and multiple myeloma. Potential side effects of targeted therapies are also mentioned.
Bortezomib for Injection Taj Pharma SmPCTajPharmaQC
Bortezomib for Injection 1mg/2mg/3.5mg Taj Pharma: Uses, Side Effects, Interactions, Pictures, Warnings, Bortezomib Dosage & Rx Info | Bortezomib Uses, Side Effects Bortezomib : Indications, Side Effects, Warnings, Bortezomib -Drug Information –Taj Pharma, Bortezomib dose Taj pharmaceuticals Bortezomib interactions, Taj Pharmaceutical Bortezomib contraindications, Bortezomib price, Bortezomib Taj Pharma Bortezomib SmPC-Taj Pharma Stay connected to all updated on Bortezomib Taj Pharmaceuticals Mumbai. Patient Information Leaflets, SMPC.
The document describes a multiple-dose methotrexate (MTX) treatment protocol for ectopic pregnancy. On treatment days 1, 3, 5, and 7, patients receive MTX injections if their human chorionic gonadotropin (hCG) levels have declined by less than 15% from the previous measurement. Leucovorin is administered on days 2, 4, 6, and 8. hCG is measured before starting treatment and on each treatment day to assess the decline. If hCG declines by more than 15%, treatment is stopped and surveillance begins. Surveillance involves weekly hCG testing until levels fall below 5 mIU/mL.
Single dose Methotrexate- Monitoring : Medical treatment ectopicAsha Reddy
The document describes two protocols for treating ectopic pregnancies with methotrexate (MTX): a multiple-dose protocol and a single-dose protocol.
The multiple-dose protocol administers MTX and leucovorin over 8 days, monitoring hCG levels after each dose. If hCG levels decline by at least 15%, treatment continues until levels fall below 5 mIU/mL. If decline is insufficient, treatment is stopped and surveillance begins.
The single-dose protocol administers a single dose of MTX on day 1 and day 7, if needed. hCG is monitored on days 1, 4, and 7 to assess the 15% decline threshold. Complete resolution usually takes 2-3
This document provides information on the fixed-dose combination drug Instgra Tafero EM, which contains dolutegravir, tenofovir alafenamide, and emtricitabine. It is used to treat HIV-1 infection in adults and pediatric patients weighing at least 30kg. The drug works by inhibiting HIV enzymes through different mechanisms of action. Common side effects include hypersensitivity reactions, liver toxicity, and immune reconstitution syndrome. Special precautions are required regarding drug interactions and use in pregnancy.
tofacitinib (Tofacent) is an oral drug used for treating rheumatoid arthritis. It belongs to a class of drugs called Janus kinase (JAK) inhibitors. buy tofacitinib only at $6. Visit our website to know more https://emergencydrug.com/drug/tofacitinib-5mg/
Methicillin resistance in Staphylococcus aureus occurs via three main mechanisms:
1) S. aureus acquires a genetic predisposition for methicillin resistance through the staphylococcal cassette chromosome mec (SCCmec) which carries the mecA gene encoding the modified penicillin-binding protein PBP2a.
2) PBP2a has reduced affinity for beta-lactam antibiotics like methicillin allowing cell wall synthesis to continue despite their presence.
3) At therapeutic methicillin levels that inhibit other PBPs, PBP2a remains active ensuring peptidoglycan cross-linking and membrane biosynthesis, enabling methicillin-resistant S. aureus (MRSA) to survive
MM151_World Lung Cancer Conference July 2011Sharlene Adams
1) MM-151 is a mixture of three human monoclonal antibodies against EGFR that were selected to simultaneously bind non-overlapping epitopes on EGFR. Computational modeling predicted that a combination of multiple EGFR antibodies would more potently inhibit signaling than single antibodies.
2) In vitro and in vivo studies showed MM-151 was more potent than existing EGFR antibodies at inhibiting signaling from various EGFR ligands. MM-151 blocked signaling from both high and low affinity ligands, whereas existing antibodies only blocked low affinity ligands.
3) Toxicology studies in animals found MM-151 to have a similar safety profile to existing EGFR antibodies, with mainly gastrointestinal and dermatological side effects. MM-151 was
Prolactin is a protein hormone secreted by the pituitary gland that enables mammals to produce milk. It binds to receptors in the gonads, lymphoid cells, and liver. Prolactin signaling triggers pathways such as JAK-STAT and MAPK that regulate cell growth and differentiation. High levels of prolactin can disrupt the hypothalamic-pituitary-gonadal axis and cause infertility by decreasing kisspeptin and GnRH expression in the brain.
Primary Human Cell Systems Analysis of Drug MechanismsBioMAP® Systems
The document summarizes a presentation about using BioMAP human cell systems to analyze the mechanisms of drug compounds, including PPAR agonists. It describes how BioMAP uses primary human cells in disease-like conditions to generate quantitative readouts that can discriminate between clinical compounds. Profiling of PPAR agonists using BioMAP revealed both shared and unique anti-inflammatory, tissue remodeling, and prostaglandin pathway effects. Differential activities suggested priorities for therapeutic areas and potential side effects.
Quantitative Analysis of IGF1R/AKT/mTOR Pathway using Multiplex-Immunoprecipi...Thermo Fisher Scientific
Determine the efficacy of multiplex IP to targeted MS (mIP-tMS) technique for measurement of the total and phosphorylated AKT-mTOR pathway targets and to evaluate whether mIP-tMS assays are as effective as the current singleplex immunoassay (Western Blot (WB) and ELISA) and multiplex Luminex assays.
The document summarizes research finding that the kinase GCN2 sustains mTORC1 suppression during amino acid deprivation by inducing the stress response protein Sestrin2. GCN2 activates the transcription factor ATF4 during amino acid starvation. ATF4 then transcriptionally upregulates Sestrin2, which is required for mTORC1 suppression. Chromatin immunoprecipitation confirms that ATF4 directly binds to the Sesn2 promoter. Sestrin2 depletion prevents mTORC1 suppression and reduces cell survival during glutamine withdrawal. Therefore, the GCN2-ATF4 pathway induces Sestrin2 to repress mTORC1 activity and promote cell survival during amino acid deprivation.
PI3KAktmTOR Intracellular Pathway and Breast Cancer Factors, Mechanism and Re...Dr Varruchi Sharma
The most recurrent cause of cancer-related deaths worldwide in women is the breast cancer. The key to diagnosis is early prediction and a curable stage but still treatment remains a great clinical challenge. Origin of the Problem: A number of studies have been carried out for the treatment of breast cancer which includes the targeted therapies and increased survival rates in women. Essential PI3K/mTOR signaling pathway activation has been observed in most breast cancers. The cell growth and tumor development in such cases involves phosphoinositide 3 kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) complex intracellular pathway. Hypothesis: Through preclinical and clinical trials, it has been observed that there are a number of other inhibitors of PI3K/Akt/mTOR pathway, which either alone or in combination with cytotoxic agents can be used for endocrine therapies. Conclusions: Structure and regulation/deregulation of mTOR provides a greater insight into the action mechanism. Also through this review, one could easily scan first and second generation inhibitors for PI3K/Akt/mTOR pathway besides targeted therapies for breast cancer and the precise role of mTOR.
Sulforaphane, found widely in broccoli, inhibits melanin synthesis and tyrosinase expression in B16 mouse melanoma cells. The study found that 5M sulforaphane inhibited melanogenesis to an equivalent level as 100M arbutin. Sulforaphane activates phosphorylated ERK and inhibits phosphorylated p38, affecting the mitogen-activated protein kinase family which controls tyrosinase expression. By regulating the MAP kinase family, sulforaphane inhibits melanogenesis and tyrosinase without cytotoxic effects, indicating it may be an effective skin-whitening agent.
1. A novel mutated chimeric tissue plasminogen activator (mt-PA) was developed by removing the first three domains of t-PA, inserting a GHRP sequence, and mutating it to resist plasminogen activator inhibitor-1 (PAI-1). 2. Mt-PA was expressed in Expi293F cells at a level of 5000 IU/mL and purified. 3. Pharmacokinetic studies in rats found mt-PA to have an elimination half-life of 19.1-26.1 minutes, plasma clearance of 3.8-5.9 mL/min, and mean residence time of 23.3-31.8 minutes - all significantly longer than wild-type
From Nutrigenomics to nutritional systems biology of fatty acid sensingNorwich Research Park
- The document discusses research into understanding the cellular responses to dietary lipids and fatty acids through nutrigenomics approaches such as transcriptomics.
- Key findings include identifying transcription factors like PPARs that sense fatty acids and regulate gene expression, as well as species-specific and tissue-specific differences in these responses.
- Models are being developed to better understand how nutrients regulate genes and pathways involved in lipid metabolism and energy homeostasis in different metabolic organs like the liver and intestine.
This document discusses how genetic polymorphisms can influence how individuals respond to drugs. It explains that genetics can account for 20-95% of variability in drug effects between people. Sequence variants in genes encoding drug-metabolizing enzymes, transporters, and targets can impact drug disposition and response. Specifically, it describes genetic polymorphisms that influence the cytochrome P450 enzyme CYP3A5 and the drug transporter P-glycoprotein, and how these affect the metabolism and transport of various medications. The document stresses that pharmacogenomic studies are helping to elucidate the inherited basis of differing drug responses.
This study investigated the relationship between MMP-9 gene expression and sialic acid (NANA) in human glial cell lines. Researchers treated glial cell lines with varying concentrations of NANA and found that MMP-9 mRNA expression increased with treatment, indicating NANA may be involved in signaling pathways regulating MMP-9 expression. The results suggest determining how NANA influences MMP-9 and other inflammatory molecules could provide insight into neurodegenerative diseases involving inflammation.
Virilizer (Vir), first isolated from Drosophila melanogaster, plays a role in sex determination. In humans, its homologue and METTL3 are involved in N6-adenosine methylation (m6A) writing. As m6A of mRNA is an important process in most eukaryotes, it is very important to understand its role and the status of factors accompanying this modification. Whole genome sequencing enables genome-wide mutation profiling in the viral mutant of Arabidopsis. https://www.cd-genomics.com/whole-genome-sequencing.html https://www.cd-genomics.com/whole-genome-sequencing.html
- The document examines the role of plasminogen activator inhibitor 1 (PAI-1) in the recruitment of mast cells (MCs) to glioma tumors.
- It finds that neutralizing PAI-1 attenuates the infiltration of MCs into glioma tumors. It also finds that MCs express the PAI-1 receptor LRP1, and blocking LRP1 also attenuates MC migration.
- Activation of the potential PAI-1/LRP1 axis in MCs by purified PAI-1 promotes increased phosphorylation of STAT3 and subsequent MC exocytosis. This indicates the PAI-1/LRP1 axis influences MC recruitment in glioma tumors.
This study investigated protein-DNA interactions within the cAMP-responsive region of the murine steroidogenic acute regulatory (StAR) protein gene. The researchers found that:
1) Steroidogenic factor 1 (SF-1) binds to an element at -95 bp (SF1-3) in the mouse StAR promoter and this site is required for full basal promoter activity.
2) SF-1 stabilizes protein-DNA interactions at the C/EBPβ/AP-1/nuclear receptor half-site (CAN) region located at -79 bp.
3) GATA-4 binds to the StAR promoter at -68 bp and contributes to approximately 20% of the cAMP-
The document discusses research into the regulation and role of the transcription factor REST in neuronal differentiation of SH-SY5Y human neuroblastoma cells exposed to IGF-I and PMA. The key findings are: 1) IGF-I and PMA increase nuclear REST levels early in treatment but REST declines with longer exposure as neurite outgrowth increases, 2) Downregulating REST with antisense oligonucleotides enhances the effects of IGF-I and PMA on neuronal markers and neurite growth, 3) REST degradation involves the ubiquitin-proteasome system and contributes to later stage neuronal differentiation. The document also analyzes the O-glycosylation pattern of REST protein in these cells.
Venters Molecular and Cellular Biology 2011 2253-2261Jordan Irvin
This study investigates the contributions of conserved regions of the essential yeast protein Mot1 to genome-wide gene regulation and transcription factor (TBP) recruitment. The researchers used a transient replacement strategy to delete conserved regions of Mot1 and analyzed the effects on gene expression and TBP occupancy. They found that the four conserved regions of Mot1 are generally required for all Mot1-regulated genes. Deletion of the ATPase region specifically altered transcriptional dependence for some genes and caused TBP to redistribute away from Mot1-inhibited genes and to other normally Mot1-independent genes. This suggests that Mot1 uses ATP hydrolysis to redistribute accessible TBP between sites of high and low intrinsic preference.
1) p53 activation through nutlin-3a treatment suppressed M2 macrophage polarization by downregulating M2 marker genes like c-MYC, IRF4 and FIZZ1.
2) Loss of p53 increased M2 macrophage polarization both in vitro and in vivo by increasing the expression of M2 marker genes.
3) p53 was found to suppress M2 macrophage polarization by directly binding to the promoter region of c-MYC gene, reducing its expression and influencing the expression of downstream M2 genes.
Similar to mTORC signaling in myfobroblast diferentiation (20)
Comparing Evolved Extractive Text Summary Scores of Bidirectional Encoder Rep...University of Maribor
Slides from:
11th International Conference on Electrical, Electronics and Computer Engineering (IcETRAN), Niš, 3-6 June 2024
Track: Artificial Intelligence
https://www.etran.rs/2024/en/home-english/
Or: Beyond linear.
Abstract: Equivariant neural networks are neural networks that incorporate symmetries. The nonlinear activation functions in these networks result in interesting nonlinear equivariant maps between simple representations, and motivate the key player of this talk: piecewise linear representation theory.
Disclaimer: No one is perfect, so please mind that there might be mistakes and typos.
dtubbenhauer@gmail.com
Corrected slides: dtubbenhauer.com/talks.html
Nucleophilic Addition of carbonyl compounds.pptxSSR02
Nucleophilic addition is the most important reaction of carbonyls. Not just aldehydes and ketones, but also carboxylic acid derivatives in general.
Carbonyls undergo addition reactions with a large range of nucleophiles.
Comparing the relative basicity of the nucleophile and the product is extremely helpful in determining how reversible the addition reaction is. Reactions with Grignards and hydrides are irreversible. Reactions with weak bases like halides and carboxylates generally don’t happen.
Electronic effects (inductive effects, electron donation) have a large impact on reactivity.
Large groups adjacent to the carbonyl will slow the rate of reaction.
Neutral nucleophiles can also add to carbonyls, although their additions are generally slower and more reversible. Acid catalysis is sometimes employed to increase the rate of addition.
The binding of cosmological structures by massless topological defectsSérgio Sacani
Assuming spherical symmetry and weak field, it is shown that if one solves the Poisson equation or the Einstein field
equations sourced by a topological defect, i.e. a singularity of a very specific form, the result is a localized gravitational
field capable of driving flat rotation (i.e. Keplerian circular orbits at a constant speed for all radii) of test masses on a thin
spherical shell without any underlying mass. Moreover, a large-scale structure which exploits this solution by assembling
concentrically a number of such topological defects can establish a flat stellar or galactic rotation curve, and can also deflect
light in the same manner as an equipotential (isothermal) sphere. Thus, the need for dark matter or modified gravity theory is
mitigated, at least in part.
The ability to recreate computational results with minimal effort and actionable metrics provides a solid foundation for scientific research and software development. When people can replicate an analysis at the touch of a button using open-source software, open data, and methods to assess and compare proposals, it significantly eases verification of results, engagement with a diverse range of contributors, and progress. However, we have yet to fully achieve this; there are still many sociotechnical frictions.
Inspired by David Donoho's vision, this talk aims to revisit the three crucial pillars of frictionless reproducibility (data sharing, code sharing, and competitive challenges) with the perspective of deep software variability.
Our observation is that multiple layers — hardware, operating systems, third-party libraries, software versions, input data, compile-time options, and parameters — are subject to variability that exacerbates frictions but is also essential for achieving robust, generalizable results and fostering innovation. I will first review the literature, providing evidence of how the complex variability interactions across these layers affect qualitative and quantitative software properties, thereby complicating the reproduction and replication of scientific studies in various fields.
I will then present some software engineering and AI techniques that can support the strategic exploration of variability spaces. These include the use of abstractions and models (e.g., feature models), sampling strategies (e.g., uniform, random), cost-effective measurements (e.g., incremental build of software configurations), and dimensionality reduction methods (e.g., transfer learning, feature selection, software debloating).
I will finally argue that deep variability is both the problem and solution of frictionless reproducibility, calling the software science community to develop new methods and tools to manage variability and foster reproducibility in software systems.
Exposé invité Journées Nationales du GDR GPL 2024
ESPP presentation to EU Waste Water Network, 4th June 2024 “EU policies driving nutrient removal and recycling
and the revised UWWTD (Urban Waste Water Treatment Directive)”
BREEDING METHODS FOR DISEASE RESISTANCE.pptxRASHMI M G
Plant breeding for disease resistance is a strategy to reduce crop losses caused by disease. Plants have an innate immune system that allows them to recognize pathogens and provide resistance. However, breeding for long-lasting resistance often involves combining multiple resistance genes
ESR spectroscopy in liquid food and beverages.pptxPRIYANKA PATEL
With increasing population, people need to rely on packaged food stuffs. Packaging of food materials requires the preservation of food. There are various methods for the treatment of food to preserve them and irradiation treatment of food is one of them. It is the most common and the most harmless method for the food preservation as it does not alter the necessary micronutrients of food materials. Although irradiated food doesn’t cause any harm to the human health but still the quality assessment of food is required to provide consumers with necessary information about the food. ESR spectroscopy is the most sophisticated way to investigate the quality of the food and the free radicals induced during the processing of the food. ESR spin trapping technique is useful for the detection of highly unstable radicals in the food. The antioxidant capability of liquid food and beverages in mainly performed by spin trapping technique.
Phenomics assisted breeding in crop improvementIshaGoswami9
As the population is increasing and will reach about 9 billion upto 2050. Also due to climate change, it is difficult to meet the food requirement of such a large population. Facing the challenges presented by resource shortages, climate
change, and increasing global population, crop yield and quality need to be improved in a sustainable way over the coming decades. Genetic improvement by breeding is the best way to increase crop productivity. With the rapid progression of functional
genomics, an increasing number of crop genomes have been sequenced and dozens of genes influencing key agronomic traits have been identified. However, current genome sequence information has not been adequately exploited for understanding
the complex characteristics of multiple gene, owing to a lack of crop phenotypic data. Efficient, automatic, and accurate technologies and platforms that can capture phenotypic data that can
be linked to genomics information for crop improvement at all growth stages have become as important as genotyping. Thus,
high-throughput phenotyping has become the major bottleneck restricting crop breeding. Plant phenomics has been defined as the high-throughput, accurate acquisition and analysis of multi-dimensional phenotypes
during crop growing stages at the organism level, including the cell, tissue, organ, individual plant, plot, and field levels. With the rapid development of novel sensors, imaging technology,
and analysis methods, numerous infrastructure platforms have been developed for phenotyping.
The use of Nauplii and metanauplii artemia in aquaculture (brine shrimp).pptxMAGOTI ERNEST
Although Artemia has been known to man for centuries, its use as a food for the culture of larval organisms apparently began only in the 1930s, when several investigators found that it made an excellent food for newly hatched fish larvae (Litvinenko et al., 2023). As aquaculture developed in the 1960s and ‘70s, the use of Artemia also became more widespread, due both to its convenience and to its nutritional value for larval organisms (Arenas-Pardo et al., 2024). The fact that Artemia dormant cysts can be stored for long periods in cans, and then used as an off-the-shelf food requiring only 24 h of incubation makes them the most convenient, least labor-intensive, live food available for aquaculture (Sorgeloos & Roubach, 2021). The nutritional value of Artemia, especially for marine organisms, is not constant, but varies both geographically and temporally. During the last decade, however, both the causes of Artemia nutritional variability and methods to improve poorquality Artemia have been identified (Loufi et al., 2024).
Brine shrimp (Artemia spp.) are used in marine aquaculture worldwide. Annually, more than 2,000 metric tons of dry cysts are used for cultivation of fish, crustacean, and shellfish larva. Brine shrimp are important to aquaculture because newly hatched brine shrimp nauplii (larvae) provide a food source for many fish fry (Mozanzadeh et al., 2021). Culture and harvesting of brine shrimp eggs represents another aspect of the aquaculture industry. Nauplii and metanauplii of Artemia, commonly known as brine shrimp, play a crucial role in aquaculture due to their nutritional value and suitability as live feed for many aquatic species, particularly in larval stages (Sorgeloos & Roubach, 2021).
Travis Hills' Endeavors in Minnesota: Fostering Environmental and Economic Pr...Travis Hills MN
Travis Hills of Minnesota developed a method to convert waste into high-value dry fertilizer, significantly enriching soil quality. By providing farmers with a valuable resource derived from waste, Travis Hills helps enhance farm profitability while promoting environmental stewardship. Travis Hills' sustainable practices lead to cost savings and increased revenue for farmers by improving resource efficiency and reducing waste.
4. Investigate the role of the mechanistic
target of rapamycin (mTOR) in
regulating TGF-b1- induced
myofibroblastic responses in human
pterygium fibroblasts (HPFs) and
elucidated the relative contributions of
mTOR signaling components.
GENERAL OBJECTIVE
13. AUTHORS SENTENCE ARTICLE
Zhao XR, Zhang MC, Xie HT, Ji N,
Ma XQ
Increased expression of mTOR in
pterygium compared to normal
conjunctiva and positive correlation
between pS6K expression and
clinical severity
Choo AY, Yoon SO, Kim SG, Roux
PP, Blenis J
The inhibitory activity of rapamycin
is not sufficient to completely block
mTORC1.
Xie J, Wang X, P Kim YC, Guan KL New generation mTOR inhibitors
have been developed and tested
for many diseases, including
cáncer
DISCUSSION
14. CONCLUSION
● Torin2 is more effective inhibitor than
rapamycin
● Importance of the different biomolecular
techniques